Cartalax: KED Cartilage Bioregulator Dosing Guide (2026)

Cartalax: KED Cartilage Bioregulator Dosing Guide (2026)
Educational use only. This article is informational and does not constitute medical advice. Peptide dosing decisions should be made in consultation with a licensed physician familiar with your medical history. Always verify any dose with your prescribing physician before drawing or administering. Some peptides discussed are not FDA-approved for human use; legal and regulatory status varies by jurisdiction.

Table of Contents

TL;DR: Cartalax is a synthetic tripeptide (Lys-Glu-Asp, KED) developed by Vladimir Khavinson’s group as the cartilage-targeted member of the short peptide bioregulator family. The mechanism proposed in Khavinson’s research is sequence-specific binding to gene promoter regions in chondrocytes, modulating expression of structural cartilage proteins. Standard biohacker / research dosing is 200–400 mcg subcutaneously daily for 10–20 days, repeated 2–3 times per year. It is not FDA-approved. There are zero Western randomized controlled trials. This guide covers the Khavinson framework, the available evidence, and what biohackers buying research-grade product should know.

For other healing peptides, see our BPC-157 guide, TB-500 guide, and GHK-Cu guide.


What Cartalax is

Cartalax is the trade name for the short tripeptide H-Lys-Glu-Asp-OH (KED), one of about 20 short peptide bioregulators in Khavinson’s catalog. The bioregulator concept: short peptides (di-, tri-, tetra-peptides) penetrate the cell and nuclear membrane, bind specific DNA sequences in promoter regions, and act as transcriptional modulators in a tissue-specific manner.

Each short peptide is paired by Khavinson’s group with a specific organ system based on extraction-of-origin and observed activity:

PeptideSequenceTarget system
CartalaxKEDCartilage
Cardiogen / Cardiogen-VLAED / AEDRHeart
BronchogenAEDG / AEDLLungs
PinealonEDRBrain (pineal-modulated)
VilonKEImmune
CortagenAEDPBrain cortex
EpitalonAEDGPineal / telomerase

Verified dosing

The Khavinson short-peptide protocol structure is consistent across the family:

ApplicationDoseRouteDurationCycle frequency
Joint / cartilage support200–400 mcgSC10–20 days2–3/year
Sublingual oral0.25–0.35 mL drops 3–4×/daySL30 days3×/year
Oral capsule2 caps daily × 30 daysPO30 days3×/year

The injectable mcg-range dose is what most Western biohackers use. Sublingual and oral formulations are sold in Russia and Eastern Europe under brand names; oral bioavailability is poor, and effect attribution at oral doses is weak.

What the research supports

Khavinson’s group has published rodent studies showing increased chondrocyte proliferation, enhanced matrix protein synthesis (collagen II, aggrecan), and reduced cartilage degradation markers in osteoarthritis models. There are no Western randomized controlled trials. The animal data is consistent with the proposed transcriptional-modulator mechanism but does not establish efficacy in human osteoarthritis or sports-related cartilage injury.

The Russian clinical literature claims benefit in osteoarthritis and post-surgical cartilage healing, but these reports are case-series and small open-label studies – not blinded RCTs.

Research-peptide buyer’s note. Cartalax is a tripeptide – among the easiest peptides to synthesize, but also frequently sold under-spec’d because the small mass means small under-fill goes undetected. Demand a Certificate of Analysis with HPLC purity ≥98%, mass spec confirming the KED sequence, and endotoxin testing. Lyophilized product is stable at −20 °C for years; reconstituted with bacteriostatic water 0.9% benzyl alcohol, refrigerate (2–8 °C), discard at 28 days. Because Cartalax is a non-natural sequence the FDA cannot regulate it as a “drug-impurity” misbranded product, but it remains research-use-only. Independent researchers running joint-health protocols should baseline a structured pain/function metric (WOMAC, KOOS) before and after each cycle to capture any signal beyond placebo.

Reconstitution

A typical 10 mg vial reconstituted with 2 mL bacteriostatic water yields 5 mg/mL = 5,000 mcg/mL. At a 200 mcg dose: 0.04 mL = 4 units on a U-100 insulin syringe. Use the Peptide Toolkit calculator for exact unit math.

Side effects and safety

The Russian clinical literature reports very few adverse events at standard doses. Most common: mild local injection-site reaction. No serious AEs documented. The biggest unknown is long-term effect of repeated cycles in humans – most Khavinson protocols recommend 2–3 cycles per year for years to decades, but Western pharmacovigilance for that pattern is essentially nonexistent.

Drug interactions

Cartalax has not been studied in any formal pharmacokinetic drug-drug interaction trial in humans. As a Khavinson tripeptide delivered sublingually or subcutaneously, its proposed gene-regulatory action on cartilage and connective tissue does not fit the standard CYP-substrate paradigm, and the evidence base is largely older Russian research without robust Western replication. Overlap with musculoskeletal drug classes is theoretical only. Always consult a prescriber before combining Cartalax with NSAIDs, corticosteroids, DMARDs, or other musculoskeletal medications.

Drug interactions to know

Published interaction data for Cartalax (AED) is limited. Always consult your prescribing physician or pharmacist before combining with prescription medications, supplements, or other substances. See our interactions lookup.

Cycle Lengths

Cycling summary: Khavinson tradition; 10-20 day courses, morning fasted, 2-3 times per year.

The typical cycle pattern for Cartalax (AED) is 2 weeks on, 12 weeks off. Users often log time-off cycles alongside on-cycles to track receptor sensitivity, biomarker recovery, and any rebound effects. The off-cycle is not a period of "washout only" but an active reset window worth using for a lab draw.

Lab Monitoring

Cartalax (AED) is a Khavinson connective-tissue-tropic tetrapeptide targeting cartilage and bone. Lab monitoring combines general-health surveillance with joint-and-bone-specific measurements where practical.

Baseline (before starting): comprehensive metabolic panel (CMP) with LFTs and renal function, CBC, hs-CRP (relevant for joint inflammation), lipid panel, vitamin D (bone metabolism), calcium and phosphorus, PTH if bone concern, TSH. Connective-tissue-specific: joint symptom score if arthritic (WOMAC or similar), DEXA scan baseline if osteopenic or age-appropriate, cartilage-turnover biomarkers CTX-II or COMP if a research-grade DTC lab is accessible (limited availability).

During and after each cycle: repeat CBC + CMP + hs-CRP after each Khavinson cycle. Repeat joint symptom score at cycle end and 2 weeks post-cycle. DEXA repeat is annual, not per cycle. Vitamin D quarterly if supplementing.

What to flag to a physician: new joint swelling or warmth, injection-site reactions persisting beyond 24 hours, unexplained bone pain, any lab value trending outside reference range across two consecutive draws.

For the full class-wide monitoring framework and a plain-language comparison of DTC lab services for peptide users, see the Peptide Lab Testing pillar guide.

Storage & Travel

Storage

Lyophilized powder: Freezer -20°C (-4°F) long-term; protect from light.

Reconstituted: Refrigerate 2-8°C (36-46°F); use within 28 days; do not freeze reconstituted. Never freeze a reconstituted vial, since freeze-thaw cycles damage peptide bonds and reduce potency.

Travel

Domestic flights: pack reconstituted vials in an insulated cooler with reusable ice packs. The TSA 3-1-1 rule limits liquids to 100 mL per container in carry-on; a 3-5 mL peptide vial passes with room to spare. Keep pharmacy or vendor documentation visible for TSA questions. Lyophilized powder in original sealed vial does not require cooling for short trips.

International travel: Cartalax (AED) is a research peptide in most jurisdictions with varying import restrictions — check the destination country’s rules before travel. Carry a physician’s letter if the peptide was prescribed by a compounding-focused clinician.

Road trips: keep the cooler in the cabin, not the trunk, during summer. Hotel mini-fridges vary in temperature stability; an insulated bag inside the mini-fridge adds a buffer.

Emergency out-of-fridge: reconstituted Cartalax (AED) at room temperature under 24 hours is generally still viable per USP stability guidance. Longer excursions or temperatures above 30°C compromise potency; discard and reconstitute a fresh vial.

How Cartalax compares

BPC-157 and TB-500 are the dominant Western “joint healing” research peptides, with broader animal data and more Western practitioner experience. Cartalax targets cartilage specifically; BPC-157 and TB-500 act through cytoprotection and angiogenesis pathways that are not cartilage-specific. GHK-Cu supports collagen synthesis but is not cartilage-targeted.

FAQ

Is Cartalax FDA-approved? No. It is a research peptide, not approved anywhere as a pharmaceutical.

What’s the standard dose? 200–400 mcg SC daily for 10–20 days, repeated 2–3 times per year.

Why cyclical dosing? The Khavinson framework holds that short-peptide bioregulators retune transcriptional programs and continued daily dosing isn’t necessary.

Is the oral form effective? Bioavailability of intact tripeptides through the gut is poor. Most Western users prefer SC.

References

  1. Khavinson VKh, Kuznik BI. Peptide Bioregulators (monograph). 2014.
  2. SeekPeptides. Khavinson peptides: complete guide.
  3. PeptideDeck. Bioregulator peptides complete guide.

Stay current on peptide research.

Monthly updates on FDA reclassification news, new dosing protocols, and calculator features. No spam, unsubscribe anytime.

Peptide updates + FDA alerts

Monthly peptide updates and important FDA alerts. No spam, unsubscribe anytime.

Join peptide patients and biohackers getting research updates straight to their inbox.

Peer-Reviewed Research

The bioregulator peptide concept has been studied extensively by V.Kh. Khavinson and the St. Petersburg Institute of Bioregulation and Gerontology. Selected peer-reviewed sources:

Similar Posts